Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.51), $0.13 worse than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.